Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 146034

AbstractMaterial and MethodsResultsDiscussionConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2023 | Month : May | Volume : 17 | Issue : 5 | Page : EC12 - EC15 Full Version

Peritumoural and Intratumoural Distribution of Langerhan Cell in Oral Squamous Cell Carcinoma and its Association with Known Prognostic Factors


Published: May 1, 2023 | DOI: https://doi.org/10.7860/JCDR/2023/61293.17818
Sandhra Papparath Usman, Deepti Ramakrishnan, S Divya

1. Assistant Professor, Department of Pathology, MES Medical College, Palachode, Perinthalmanna, Kerala, India. 2. Professor, Department of Pathology, Amala Institute of Medical Sciences, Thrissur, Kerala, India. 3. Associate Professor, Department of Pathology, Amala Institute of Medical Sciences, Thrissur, Kerala, India.

Correspondence Address :
Dr. Sandhra Usman,
Assistant Professor, Department of Pathology, MES Medical College, Perinthalmanna-679321, Kerala, India.
E-mail: snu.usman@gmail.com

Abstract

Introduction: Oral Squamous Cell Carcinoma (OSCC) accounts for about 2/3rd of the Head and Neck Squamous Cell Carcinomas (HNSCC). It is the sixth most common cancer worldwide and the third most common cancer in developing countries including India. More than half the HNSCC patients have advanced disease at the time of diagnosis and overall long-term survival is low (50%), despite aggressive therapeutic regimens. This has demanded the need for prognostic indicators that can be used to improve the ability to select a more individualised approach for treatment relative to the risks of recurrence, metastases and death.

Aim: To study the intratumoural and peritumoural distribution and density of Langerhans Cells (LC) in OSCC using Immunohistochemistry (IHC) markers Cluster of Differentiation-1a (CD1a) and Langerin and to study its association with known prognostic factors.

Materials and Methods: This was a hospital-based cross-sectional study conducted at the Department of Pathology, Amala institute of Medical Sciences, Kerala, India during a period of 18 months, from January 2019 to June 2020. In total, 28 specimens of wide local excision with cervical lymph node dissection done for OSCC were enrolled in the study. Small biopsy samples and cases who had undergone neoadjuvant treatment as well as cases of recurrent OSCC were excluded. Clinical details were obtained from the patients’ case files. The immunohistochemical staining for LCs using CD1a and Langerin was done. The distribution of LCs was compared to the tumour grade and lymph node status along with lymphovascular and perineural invasion. Statistical analysis was performed using sample t-test after identifying normality of distribution. The p-value of <0.05 was taken as significant.

Results: Fourteen cases of well differentiated and 14 cases of moderate to poorly differentiated OSCC were selected for the study. The LC distribution in these cases was compared to prognostic factors like histological grade, Lymphovascular Invasion (LVI), perineural invasion, tumour size, depth of invasion, T stage and lymph node status. A significant positive association was observed between the tumour differentiation and peritumoural CD1a positive cell density (p-value: 0.001). Further, a negative association was also established between the lymph node staging and peritumoural CD1a positive cell density (p-value: 0.004). There was no association between the LC density and presence of lymphovascular or perineural invasion in OSCC.

Conclusion: A depleted peritumoural LC density in OSCC reflects poor tumour immunity, associated with higher grade and higher stage of lymph node metastasis. LC density may hence be of prognostic value in OSCC.

Keywords

Cluster of differentiation1a, Dendritic cells, Langerin

The OSCC accounts for about 2/3rd of the HNSCC. It is the sixth most common cancer worldwide and the third most common cancer in developing countries like India (1),(2). In India, OSCC is the most common cancer among men and fourth most common among women, contributing about 2/3rd of the global burden (3). The prognosis of OSCC is related to various factors such as histological grade, tumour location, tumour size, involvement of adjacent tissues and metastasis at the time of diagnosis (4),(5),(6),(7),(8),(9),(10). The GLOBOCAN project in 2018 estimated a global age-standardised incidence rate of 3.5 per 1,00,000 population per year and global mortality rate of 1.77 deaths per 1,00,000 population per year (11). More than half of all HNSCC patients have advanced disease at the time of diagnosis with a poor overall survival rate of five years and a low overall long-term survival (50%), despite aggressive therapeutic regimens (12),(13). This has demanded the need for prognostic indicators that can be used to improve the ability to select a more individualised approach for treatment relative to the risks of recurrence, metastases and death. LCs belongs to a population of antigen presenting cells in the epidermis and mucous membranes which may play an important role in the immunological defence mechanism against epithelial tumours (4). Several immunohistochemical markers targeting LCs have been identified, such as S100, Cd1a, CD83, Langerin (CD207), CD208, CD80, CD11c, CD86 and HLA -DR (Human Leukocyte Antigen – DR isotype) (14). Langerin and CD1a are specific immunohistochemical markers of LCs (15). Present study was aimed to identify the distribution of LCs in OSCC intratumourally and peritumourally and compare it with the established prognostic and theranostic factors of OSCC including tumour size, tumour grade, tumour thickness, LVI and cervical lymph node metastasis to evaluate the prognostic impact of LCs in OSCC.

Material and Methods

This was a descriptive cross-sectional study conducted at the Department of Pathology, Amala Institute of Medical Sciences, Kerala, India. The study was conducted during a period of 18 months from January 2019 to June 2020. The cases histologically diagnosed as OSCC during this period were enrolled in the study. A total of 28 cases were studied, after obtaining approval from the Institutional Research and Ethical Committee (IEC no: AIMSIEC/27/2018).

Inclusion criteria: All wide excision specimens of OSCC with lymph node dissection, received at the Department of Pathology from January 2019 to June 2020 were included in this study.

Exclusion criteria: Cases that underwent neoadjuvant chemotherapy or radiotherapy for OSCC, recurrent cases of OSCC and small biopsy samples of OSCC were excluded from this study.

Study procedure: A total of 28 wide excision specimens of OSCC along with lymph node dissection received at the Department of Pathology, Amala Institute of Medical Sciences, satisfying both the inclusion and exclusion criteria were enrolled for the study. A predesigned proforma was used to document the relevant patient variables and pathological details required for the study. Relevant clinical information (age, gender, tobacco smoking, alcohol consumption), were taken from the case records and histopathology requisition forms of the patient. Grossing of specimens was performed according to standard College of American Pathologists (CAP) protocol (16). Histological diagnosis were rendered on properly oriented, formalin fixed, paraffin embedded, Haematoxylin and Eosin stained sections (4 μ thickness). Paraffin blocks containing tumour proper along with adequate peritumoural stroma were selected for each case. A 4 μ thick section were cut and mounted on three glass slides for each case. H&E staining was done on one of the sections. On the other two, IHC staining was performed using the markers Rabbit Monoclonal Anti-CD1a Antibody and Rabbit MonoclonalAnti-Langerin Antibody. LCs were assessed following IHC staining.

Relevant findings (histological grade, LVI, perineural invasion, tumour size, depth of invasion, TNM staging and lymph node status) were recorded.

The cases were reviewed and morphologically classified into two groups-well differentiated OSCC and moderately to poorly differentiated OSCC, similar to the study by Jardim JF et al., (14).

Tumours were categorised based on their size as: 0-2 cm, >2-4 cm and >4 cm, as categorised in the TNM staging. Lymphovascular and perineural invasion were assessed on H&E sections.

Maximum depth of invasion was determined by the infiltration of the tumour as measured from the nearest uninvolved mucosal surface. They were categorised as: 0-0.5 cm; >0.5-1 cm and >1 cm (16).

Staging of the tumours were done based on the AJCC staging system, 8th edition (17).

Evaluation of LCs on IHC stained slides: Cells with membranous staining with CD1a and Langerin were considered as CD1a positive and Langerin positive cells, respectively, as per reagent specifications. Four fields of 1 mm2 for both, intratumoural and peritumoural LCs were selected. The results were expressed as the mean positive count staining of the four areas analysed that were translated into the density of cells per mm2 (14).

Statistical Analysis

Data was entered in MS Excel worksheets and analysed using Statistical Package for the Social Sciences (SPSS) version 23.0 statistical software. Descriptive and inferential statistical analysis was carried out. Results on continuous measurements were presented on mean standard deviation and results on categorical measurements were presented in number (%). Significance assessed at 5% level. Normality of data was tested using Shapiro-Wilk test. If normal, the difference between intratumoural and peritumoural density of LCs was analysed by independent sample t-tests. The statistical significance was considered when p-value <0.05.

Results

The patient age ranged from 42 to 82 years, with the maximum number of cases (11 cases) in this study between the age group of 61-70 years, closely followed by nine patients between the ages of 51 and 60. Six of the remaining patients were over the age of 70 and only two patients below 50 years of age. The mean age at 13diagnosis was 63.03±9.57 years. The study group of 28 patients showed a male predominance with 19 (67.86%) males and nine (32.14%) females.

Thirteen of 28 patients (46.4%) gave history of smoking (all of which were males) while the remaining were never smokers. Seven patients (25%) gave history of alcoholism (all of which were males) and the other 21 (75%) patients were teetotallers.

The most common site involved was the tongue, accounting for 16 cases (57.14%). The rest of the sites in order of their incidence were Buccal mucosa: 4 (14.28%), Alveolar ridge: 3 (10.71%), Floor of mouth: 2 (7.14%), Angle of mouth: 2 (7.14%) and Lip: 1 (3.57%).

There were an equal number of 14 cases (50%) each of well differentiated OSCC (Table/Fig 1) and moderately to poorly differentiated OSCCs. Among the latter category, 13 cases were moderately and one case was poorly differentiated OSCC (Table/Fig 2).

Only 2 (7.14%) cases showed evidence of LVI and 6 (21.4%) cases showed evidence of perineural invasion. Majority of the tumours were of size within 4 cm in maximum diameter with 13 cases of size 0-2 cm and 12 cases of size >2-4 cm. Twelve cases showed a depth of invasion of less than or equal to 0.5 cm and nine cases had a depth of invasion of over 1 cm.

T stage: Of the 28 cases, 9 (32%) belonged to T1 category, 11 (39%) to T2, 4 (14.5%) to T3 and 4 (14.5%) to T4 categories.

N stage: A 78% of the cases accounting for 22 of the 28 cases showed no nodal involvement. Of the remaining six cases that showed nodal involvement, 3 (11%) belonged to N1, 2 (7%) belonged to N2 and 1 (4%) of the cases belonged to N3 nodal status.

M stage: None of the cases show evidence of metastasis.

Association between the pathological parameters (histological grade, LVI, perineural invasion, tumour size, depth of invasion, TNM staging and lymph node status) and the density of intratumoural and peritumoural LCs were analysed (Table/Fig 3),(Table/Fig 4),(Table/Fig 5),(Table/Fig 6).

Statistically, peritumoural CD1a positive cell distribution showed significant negative association with histological grade, with a p-value of 0.001. Similar association was also noted with intratumoural LC distribution without statistical significance. The LC distribution showed no association to the presence or absence of LVI, perineural invasion or tumour size. There was a significant decrease in peritumoural LC density in tumours with a depth of invasion of more than 1 cm than in those less than 1 cm (p-value: 0.05). No significant difference was noted in intratumoural LC density and depth of invasion.

The intratumoural LCs showed an increase in density with tumour stage (T1 to T3), which reflected increase in intratumoural LCs with increase in tumour size and depth. However, T4 stage was associated with least intratumoural LC density (p-value: 0.038). There was no association between peritumoral LC density and T stage. The LC distribution was compared to the lymph node status. Peritumoural LCs showed a negative association with the lymph node (N) status (p-value 0.004). No similar association was noted with intratumoural LC density (Table/Fig 7).

Discussion

The OSCC is one of the leading causes of mortality worldwide. This may be attributed to the high propensity for local and nodal metastasis of this tumour. Hence, this neoplasm has been extensively studied to determine its various prognostic factors. Over the past decade, the role of inflammatory cells in various tumours is being explored. Immunology of oral diseases has been focused on tumour antigens and lymphocytes. Of equal importance are Antigen Presenting Cells (APCs) such as LCs of the epithelium that are initiators and modulators of immune response.

In this study, authors had compared the density and distribution of LCs in OSCC, to various clinicopathological parameters. IHC markers CD1a and Langerin (CD207) to identify the LCs in sections were used.

Histological Grade

A total of 28 cases of OSCC were selected for the current study. LC density in Intratumoural and Peritumoural zones were assessed using IHC stains: CD1a and Lanegrin. A higher density of peritumoural CD1a-positive cells was observed in well differentiated OSCC as compared to the moderate to poorly differentiated group of OSCC, which showed statistical significance (p-value: 0.001). Although not statistically significant, a similar distribution proportion was seen in peritumoural Langerin positive cells as well. In their study, Jardim JF et al., conducted the study using IHC markers CD1a and CD83 to identify LC. They identified a tendency to statistical significance between the diminished counts of intratumoural CD83+

with histological grade (p-value=0.08) (14). In a study by Lasisi TJ et al., the number of LCs (highlighted by CD1a) was significantly reduced in high-grade OSCC as compared to low grade OSCC, with a p-value of 0.001 (4). In their study, the LC density in tumour tissue was compared to that in the overlying or adjacent normal epithelium. In present study, the intratumoural LC density (highlighted by both CD1a and Langerin) were lower in moderate to poorly differentiated group as compared to the well differentiated group. However, this finding was not statistically significant.

Lymphovascular Invasion (LVI)

Present study analysed the LVI on H&E on all cases. Presence of LVI is associated with a worse prognosis in OSCC. Intratumoural and peritumoural LC density in OSCC was reduced in cases with LVI as compared to those without LVI. However, this association was not statistically significant (p-value >0.05) with both CD1a and Langerin positive cells. In the study by Jardim JF et al., no association was observed between the two parameters (14).

Perineural Invasion

Perineural invasion is one of the known prognostic indicators of OSCC and is associated with poor outcome. In this study, authors compared the LC density to the perineural invasion status in all the cases. No significant association could be made between the two parameters. Intratumoural and peritumoural LC densities hence have no direct association with perineural invasion. This was in line with the findings in study done by Jardim JF et al., where no significant association was seen between LC density in OSCC and the presence of perineural invasion (14).

Tumour Size

In this study, authors examined the association of the tumour size, to the LC distribution. No significant association could be established. Jardim JF et al., in their study, was also unable to establish any direct association between the two parameters (14).

Depth of Invasion

The depth of invasion was compared with the intratumoural and peritumoural LCs. Present study noted a significant depletion of peritumoural LCs with a depth of invasion of more than 1 cm as compared to those less than 1 cm (p-value of 0.05). A similar association was seen in a study performed by Wei N and Tahan SR, on OSCC of the lip. They noted a depletion in the peritumoural LC with increasing depth of invasion (p-value=0.04) (18).

Tumour Stage

An elevation in intratumoural CD1a positive LC density was noted with an increase in tumour stage, from T1 to T3 (AJCC staging). This association was significant with a p-value of 0.038. No significant association was established between the T stage and LC distribution in the study by Jardim JF et al., (14).

Lymph Node Status

In this study, a decreasing peritumoural CD1a positive LC density was seen with increasing nodal stage. The association between the two parameters was statistically significant (p-value: 0.004). In the study by Jardim JF et al., a similar association was noted between Lymph node metastasis and the peritumoural LC density (p-value=0.05). Goldman SA et al., also made a similar observation in their study; with a p-value of 0.01 (19). In present study, a similar trend was noted in Langerin positive cells. However, no statistical significance was established.

Limitation(s)

The limited sample size and paucity of poorly differentiated OSCC cases included in the study may pose to be limitations to this study.

Conclusion

A depleted peritumoural density of CD1a positive LC density in OSCC is likely to reflect poor tumour immunity. The use of LC as an independent prognostic indicator of OSCC needs to be further evaluated. This may, in future, aid the development of immunotherapy triggering LCs in OSCC.

References

1.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Vol. 45, Oral Oncology. Elsevier Ltd; 2009. pp. 309-16. [crossref][PubMed]
2.
Babu KG. Oral cancers in India. Semin Oncol. 2001;28(2):169-73. [crossref][PubMed]
3.
Rani SV, Aravindha B, Leena S, Balachander N, Malathi LK, Masthan MK. Role of abnormal Langerhans cells in oral epithelial dysplasia and oral squamous cell carcinoma: A pilot study. J Nat Sci Biol Med. 2015;6(Suppl 1):S128-33. [crossref][PubMed]
4.
Lasisi TJ, Oluwasola AO, Lasisi OA, Akang EE. Association between langerhans cells population and histological grade of oral squamous cell carcinoma. Journal of Oral and Maxillofacial Pathology. 2013;17(3):329-33. [crossref][PubMed]
5.
Kademani D, Bell RB, Bagheri S, Holmgren E, Dierks E, Potter B, et al. Prognostic factors in intraoral squamous cell carcinoma: The influence of histologic grade. Journal of Oral and Maxillofacial Surgery. 2005;63(11):1599-605. [crossref][PubMed]
6.
Shah JP. Cervical lymph node metastases--diagnostic, therapeutic, and prognostic implications. Oncology (Williston Park) [Internet]. 1990 Oct 1 [cited 2020 Aug 15];4(10):61-69; discussion 72, 76. Available from: http://www.ncbi. nlm.nih.gov/pubmed/2149826.
7.
Warnakulasuriya S. Prognostic and predictive markers for oral squamous cell carcinoma: The importance of clinical, pathological and molecular markers. Saudi J Med Med Sci. 2014;2(1):12. [crossref]
8.
Woolgar JA, Rogers SN, Lowe D, Brown JS, Vaughan ED. Cervical lymph node metastasis in oral cancer: The importance of even microscopic extracapsular spread. Oral Oncol. 2003;39(2):130-37. [crossref][PubMed]
9.
Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: A review of the literature. Head and Neck. 2005;27:1080-91. [crossref][PubMed]
10.
Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(4):423-31. [crossref][PubMed]
11.
The Global Cancer Observatory. Lip, oral cavity- international agency for research on cancer [Internet]. 2020. Available from: https://gco.iarc.fr/today/ data/factsheets/cancers/1-Lip-oral-cavity-fact-sheet.pdf.
12.
Sathiyasekar AC, Chandrasekar P, Pakash A, Kumar KUG, Jaishlal MS. Overview of immunology of oral squamous cell carcinoma. Journal of Pharmacy and Bioallied Sciences. Medknow Publications; 2016;8:S8-12. [crossref][PubMed]
13.
Curado MP, Johnson NW, Kerr AR, Silva DRM e, Lanfranchi H, Pereira DL, et al. Oral and oropharynx cancer in South America. Translational Research in Oral Oncology [Internet]. 2016 Aug 3 [cited 2020 Jul 19];1:2057178X1665376. [crossref]
14.
Jardim JF, Gondak R, Galvis MM, Pinto CAL, Kowalski LP. A decreased peritumoral CD1a+cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology. 2018;72(6):905-13. [crossref][PubMed]
15.
Mizumoto N, Takashima A. CD1a and langerin: Acting as more than Langerhans cell markers. J Clin Invest. 2004;113(5):658-60. [crossref][PubMed]
16.
College of American Pathologists. Protocol for the examination of specimens from patients with cancers of the lip and oral cavity. 2017 [cited 2023 Jan 24]. Available from: www.cap.org/cancerprotocols.
17.
Amin MB et al. (Eds. ). AJCC Cancer Staging Manual (8 th edition). 2018.
18.
Wei N, Tahan SR. S100+cell response to squamous cell carcinoma of the lip: Inverse correlation with metastasis. J Cutan Pathol. 1998;25(9):463-68. [crossref][PubMed]
19.
Goldman SA, Baker E, Weyant RJ, Clarke MR, Myers JN, Lotze MT. Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma. Archives of Otolaryngology-Head and Neck Surgery [Internet]. 1998 [cited 2020 Sep 26];124(6):641-46.[crossref][PubMed]

DOI and Others

DOI: 10.7860/JCDR/2023/61293.17818

Date of Submission: Nov 16, 2022
Date of Peer Review: Jan 19, 2023
Date of Acceptance: Apr 03, 2023
Date of Publishing: May 01, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was Ethics Committee Approval obtained for this study? Yes
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Nov 21, 2022
• Manual Googling: Feb 22, 2023
• iThenticate Software: Mar 07, 2023 (6%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com